Hidetoshi Shimizu

4PUBLICATIONS
13CO-AUTHORS
PharmacogenomicsBiomolecular modelling and design
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Aug 16, 2024
First-in-human study evaluating safety, pharmacokinetics, and pharmacodynamics of lorundrostat, a novel and highly selective aldosterone synthase inhibitor.

Hidetoshi Shimizu, Michael A Tortorici, Yoshiyasu Ohta

|Feb 29, 2024
Publisher Correction: Evaluation of Age-Related Changes in Teneligliptin Pharmacokinetics in Japanese and European Descent Subjects Using a Physiologically Based Pharmacokinetic Model.

Hiroaki Iijima, Hidetoshi Shimizu, Kazumi Mori-Anai

|Dec 20, 2023
Evaluation of Age-Related Changes in Teneligliptin Pharmacokinetics in Japanese and European Descent Subjects Using a Physiologically Based Pharmacokinetic Model.

Hiroaki Iijima, Hidetoshi Shimizu, Kazumi Mori-Anai

|Jun 03, 2021
Prediction of human pharmacokinetics for low-clearance compounds using pharmacokinetic data from chimeric mice with humanized livers.

Kosuke Yoshida, Yuki Doi, Norihiko Iwazaki

Pageof 1